New cream could zap precancerous skin spots

NCT ID NCT07340697

Recruiting now Disease control Sponsor: Rubedo Life Sciences, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new cream called RLS-1496 for actinic keratosis, rough patches that can turn into skin cancer. About 24 adults will apply the cream to one forearm daily for 28 days, leaving the other arm untreated for comparison. Researchers will check if the cream is safe and whether it reduces or clears the spots.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS (AK) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

actinic keratosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACTINIC KERATOSIS (AK)

Contacts and locations

Show contact details

Locations

Austin Institute for Clinical Research
RECRUITING

Pflugerville, Texas, 78660, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Burke Pharmaceutical Research
RECRUITING

Hot Springs, Arkansas, 71913, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Minnesota Clinical Study Center
RECRUITING

New Brighton, Minnesota, 55112, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Schlessinger MD Skin Research Center
RECRUITING

Omaha, Nebraska, 68144, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.